Protalix BioTherapeutics, Inc. (PLX) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

• Protalix BioTherapeutics, Inc. PLX 2.61 ▼ −3.33%
• Zentalis Pharmaceuticals, Inc. ZNTL 2.13 ▼ −4.91%

Protalix BioTherapeutics, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Protalix BioTherapeutics, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($217.5M and $212.1M). Zentalis Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.4×. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs 0.00%). Across the 14 metrics below, Protalix BioTherapeutics, Inc. leads on 9 and Zentalis Pharmaceuticals, Inc. on 5.